Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May-Jun;27(3):244-54.
doi: 10.1111/j.1525-1470.2009.01078.x. Epub 2010 Apr 9.

Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008

Affiliations

Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008

David R Berk et al. Pediatr Dermatol. 2010 May-Jun.

Abstract

Pediatric melanoma is difficult to study because of its rarity, possible biological differences in preadolescents compared with adolescents, and challenges of differentiating true melanoma from atypical spitzoid neoplasms. Indeterminant lesions are sometimes designated as melanocytic tumors of uncertain malignant potential (MelTUMPs). We performed a retrospective, single-institution review of melanomas, MelTUMPs and Spitz nevi with atypical features (SNAFs) in patients at 21 years of age and younger from 1995 to 2008. We identified 13 patients with melanoma, seven with MelTUMPs, and five with SNAFs. The median age for melanoma patients was 17 years, 10 for MelTUMPs, and six for SNAFs. Of the 13 melanoma patients, only four were younger than 15 years, while six were adolescents, and three were young adults. Nine melanoma patients (69%) were female. The most common histologic subtype was superficial spreading. The median depth for melanomas was 1.2 mm, and 3.4 mm for MelTUMPs. Microscopic regional nodal involvement detected on elective or sentinel lymph node (SLN) dissection was present in 2/10 (20%) of primary melanomas and 2/6 (33%) of Mel-TUMPs. Complete lymphadenectomy was performed on four melanoma patients, with three positive cases. Patient outcome through March 31, 2009 revealed no in-transit or visceral metastasis in patients with MelTUMPs or SNAFs. One SLN-positive patient (8%) with melanoma developed recurrent lymph node and liver metastasis and died 15 months after primary diagnosis. Our data highlight the rarity, female predominance, and significant rate of SLN positivity of pediatric melanoma. The high rate of MelTUMPs with regional nodal disease reinforces the need for close follow-up.

PubMed Disclaimer

Similar articles

Cited by

  • Giant congenital nodular melanoma in a newborn: a case report and literature review.
    Zhou J, Lv MX, Duan L, Xie YC, A ZX, Wu HF, Gao Y. Zhou J, et al. BMC Pediatr. 2021 Mar 11;21(1):121. doi: 10.1186/s12887-021-02590-7. BMC Pediatr. 2021. PMID: 33706747 Free PMC article. Review.
  • An 18-year Study of Malignant Melanoma in Childhood and Adolescence.
    Al-Himdani S, Naderi N, Whitaker IS, Jones NW. Al-Himdani S, et al. Plast Reconstr Surg Glob Open. 2019 Aug 30;7(8):e2338. doi: 10.1097/GOX.0000000000002338. eCollection 2019 Aug. Plast Reconstr Surg Glob Open. 2019. PMID: 31592003 Free PMC article.
  • Sentinel Node Biopsy in Young Patients with Atypical Melanocytic Tumors of the Head and Neck.
    Pfau D, Tamaki A, Hoppe KR, Honda K, Rezaee R, Zender CA. Pfau D, et al. OTO Open. 2019 May 29;3(2):2473974X19850752. doi: 10.1177/2473974X19850752. eCollection 2019 Apr-Jun. OTO Open. 2019. PMID: 31428727 Free PMC article.
  • MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort.
    Pellegrini C, Botta F, Massi D, Martorelli C, Facchetti F, Gandini S, Maisonneuve P, Avril MF, Demenais F, Bressac-de Paillerets B, Hoiom V, Cust AE, Anton-Culver H, Gruber SB, Gallagher RP, Marrett L, Zanetti R, Dwyer T, Thomas NE, Begg CB, Berwick M, Puig S, Potrony M, Nagore E, Ghiorzo P, Menin C, Manganoni AM, Rodolfo M, Brugnara S, Passoni E, Sekulovic LK, Baldini F, Guida G, Stratigos A, Ozdemir F, Ayala F, Fernandez-de-Misa R, Quaglino P, Ribas G, Romanini A, Migliano E, Stanganelli I, Kanetsky PA, Pizzichetta MA, García-Borrón JC, Nan H, Landi MT, Little J, Newton-Bishop J, Sera F, Fargnoli MC, Raimondi S; IMI Study Group; GEM Study Group; M-SKIP Study Group. Pellegrini C, et al. Lancet Child Adolesc Health. 2019 May;3(5):332-342. doi: 10.1016/S2352-4642(19)30005-7. Epub 2019 Mar 12. Lancet Child Adolesc Health. 2019. PMID: 30872112 Free PMC article.
  • Clinical features and outcomes of spitzoid proliferations in children and adolescents.
    Bartenstein DW, Fisher JM, Stamoulis C, Weldon C, Huang JT, Gellis SE, Liang MG, Schmidt B, Hawryluk EB. Bartenstein DW, et al. Br J Dermatol. 2019 Aug;181(2):366-372. doi: 10.1111/bjd.17450. Epub 2019 Feb 10. Br J Dermatol. 2019. PMID: 30467833 Free PMC article.

MeSH terms

LinkOut - more resources